ECSP024236A - CHEMICAL DERIVATIVES AND THEIR APPLICATION AS AN ANTITELOMERASA AGENT - Google Patents

CHEMICAL DERIVATIVES AND THEIR APPLICATION AS AN ANTITELOMERASA AGENT

Info

Publication number
ECSP024236A
ECSP024236A EC2002004236A ECSP024236A ECSP024236A EC SP024236 A ECSP024236 A EC SP024236A EC 2002004236 A EC2002004236 A EC 2002004236A EC SP024236 A ECSP024236 A EC SP024236A EC SP024236 A ECSP024236 A EC SP024236A
Authority
EC
Ecuador
Prior art keywords
antitelomerasa
application
agent
chemical derivatives
new
Prior art date
Application number
EC2002004236A
Other languages
Spanish (es)
Inventor
Patrick Mailliet
Abdelazize Laoui
Jean Francois Riou
Gilles Doerflinger
Jean Louis Mergny
Francois Hamy
Thomas Caulfield
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Publication of ECSP024236A publication Critical patent/ECSP024236A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

El presente invento es relativo a la terapia del cáncer y se relaciona con los nuevos agentes anticancerígenos que tienen un mecanismo de acción particular. Implica también los nuevos compuestos químicos así como su aplicación terapéutica en el hombre.The present invention is related to cancer therapy and relates to new anticancer agents that have a particular mechanism of action. It also implies the new chemical compounds as well as their therapeutic application in man.

EC2002004236A 2001-03-23 2002-03-22 CHEMICAL DERIVATIVES AND THEIR APPLICATION AS AN ANTITELOMERASA AGENT ECSP024236A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0103916A FR2822468B1 (en) 2001-03-23 2001-03-23 CHEMICAL DERIVATIVES AND THEIR APPLICATION AS ANTI-TELOMERASE AGENT

Publications (1)

Publication Number Publication Date
ECSP024236A true ECSP024236A (en) 2003-10-28

Family

ID=8861454

Family Applications (1)

Application Number Title Priority Date Filing Date
EC2002004236A ECSP024236A (en) 2001-03-23 2002-03-22 CHEMICAL DERIVATIVES AND THEIR APPLICATION AS AN ANTITELOMERASA AGENT

Country Status (3)

Country Link
EC (1) ECSP024236A (en)
FR (1) FR2822468B1 (en)
UY (1) UY27211A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ563245A (en) * 2005-05-19 2011-04-29 Prometic Biosciences Inc Triazine compounds and compositions thereof for the treatment of cancers

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9206768D0 (en) * 1992-03-27 1992-05-13 Jarman Michael New compounds for use in the treatment of cancer
JPH1160573A (en) * 1997-08-22 1999-03-02 Nippon Kayaku Co Ltd Triazine derivative and telomerase inhibitor
US6262053B1 (en) * 1999-06-23 2001-07-17 Parker Hughes Institute Melamine derivatives as potent anti-cancer agents
HUP0204429A2 (en) * 1999-11-29 2003-04-28 Aventis Pharma S.A. Arylamine derivatives and their use as anti-telomerase agent

Also Published As

Publication number Publication date
FR2822468A1 (en) 2002-09-27
FR2822468B1 (en) 2008-06-20
UY27211A1 (en) 2002-08-30

Similar Documents

Publication Publication Date Title
UY26456A1 (en) COMPOUNDS THAT FIX THE G-QUADRUPLEX STRUCTURE OF TELOMERES, TRIAZINS FOR THE APPLICATION OF SUCH COMPOUNDS, THE USE OF SUCH COMPOUNDS AS PHARMACEUTICAL PRODUCTS AND INCLUDING THERAPEUTICAL ASSOCIATIONS.
UY28213A1 (en) NEW CYANOPIRIDINE DERIVATIVES USEFUL IN THE TREATMENT OF CANCER AND OTHER DISORDERS.
ECSP055911A (en) INHIBITING TRICYCLIC COMPOUNDS OF PROTEIN KINASE TO IMPROVE THE EFFECTIVENESS OF ANTINEOPLASSIC AGENTS AND RADIATION THERAPY
CY1122417T1 (en) METHODS AND COMPOSITIONS FOR EXTENDED DRUG DELIVERY
PA8513101A1 (en) DERIVATIVES OF ETERES DE PIRAZOL AS ANTI-INFLAMMATORY / ANALGESIC AGENTS
CY1112387T1 (en) THERAPEUTIC COMPOSITION CONTAINING TOULAHISTON A PRODUCER OF PYRROLOVENZODIAZEPIN AND FLUDARABIN
BRPI0809164B8 (en) COMPOSITION FOR TOPICAL ADMINISTRATION AND PHARMACEUTICAL COMPOSITION COMPRISING SAID COMPOSITION
UY27890A1 (en) THERAPEUTIC TREATMENT
DOP2010000141A (en) BREAST CANCER TREATMENT WITH A PARP INHIBITOR ONLY OR IN COMBINATION WITH ANTI-TUMOR AGENTS
HN2001000244A (en) SPIROPIRIMIDIN INHIBITORS - 2, 4, 6 - TRIONA METALOPROTEINASAS.
PA8479201A1 (en) DERIVATIVES OF HYDROXY ACID-HYDROXAMIC PIPECOLATE
DOP2005000248A (en) CYTOTOXIC AGENTS WHO UNDERSTAND NEW.
GT200500026A (en) DERIVATIVES OF BETA-AMINOACIDOS AS INHIBITORS OF FACTOR XA.
PA8654601A1 (en) CYTOTOXIC AGENTS UNDERSTANDING NEW TAXANS
UY32739A (en) COMBINATIONS OF CHEMOTHERAPIC AGENTS AND ANTAGONISTS DLL4 AND ITS USES IN CANCER THERAPY
UY27812A1 (en) USE OF DOCETASEL-DOXORUBIN-CICLOFOSFAMIDA AS A THERAPY SUPPORT
BRPI0518448A2 (en) pharmaceutical compositions comprising a camptothecin derivative
PA8508201A1 (en) HETEROCICLO-ALQUILSULFONIL PIRAZOLO DERIVATIVES AS ANTI-INFLAMMATORY / ANALGESIC AGENTS
HN2003000063A (en) NICOTINAMIDE DERIVATIVES AND A COMBINATION TIOTROPIO SALT FOR THE TREATMENT OF DISEASES.
PA8553101A1 (en) FORMULATIONS IN COMBINATION OF PROPANOL-AMINA DERIVATIVES SUBSTITUTED WITH ARILO, TOGETHER WITH OTHER ACTIVE SUBSTANCES AND ITS USE
ES2723778T3 (en) Therapy directed at cancer stem cells and against drug-resistant cancer
CL2007002878A1 (en) PHARMACEUTICAL AGENT UNDERSTANDING 1) AN HER2 INHIBITOR THAT HAS A PIRROLOPIRIMIDINE OR PIRAZOLOPIRIMIDINE SKELETON AND 2) A HORMONAL OR ANTI-BANK THERAPEUTIC AGENT IN COMBINATION; AND USE FOR THE PREVENTION OR TREATMENT OF CANCER.
MY130957A (en) Triazine derivatives and their application as antitelomerase agents
ECSP024236A (en) CHEMICAL DERIVATIVES AND THEIR APPLICATION AS AN ANTITELOMERASA AGENT
SV2001000212A (en) A COMBINATION OF ANTINEOPLASTIC AGENTS THAT INCLUDE ACETILDINALINE AND PACLITAXEL AND / OR CARBOPLATIN AND GAME THAT INCLUDES IT